Indefinite Delivery Contract 75N95022D00023
Award Date
9/28/22
Last Date to Order
9/29/30
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
541512 - Computer Systems Design Services
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency of the U.S. government. The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods specializing in biopharmaceutical research and development. The IDC, valued at a ceiling of $48,882,666, covers a broad range of pharmacology studies, animal model development, and...
The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an indefinite-delivery/indefinite-quantity multiple award contract to Battelle Memorial Institute for Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders. The original solicitation sought to procure manufacturing and nonclinical services over five years to support the development of biotechnology products for...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a leading contract research and manufacturing organization. The $80 million IDC is for manufacturing and characterization services for vaccines and other biologics targeting infectious diseases. Under this IDC, ABL has been issued multiple task orders for a range of...
This is a single-award Indefinite Delivery Contract (IDC) issued by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The base contract has a potential value of $124,500,000 and a period of performance through September 28, 2028. The purpose is to provide NIAID Preclinical Development Support...
This Indefinite Delivery Contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL). The $49.9 million, multiple-award IDC will provide Chemistry, Manufacturing, and Control (CMC) and related services to support the development of drug products from August 2024 through July 2031. The contract aims to obtain a broad range of preclinical services...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services (HHS), has awarded a Blanket Purchase Agreement (BPA) to Eurofins Genomics LLC, a for-profit manufacturer of goods. The $10,000,000 single-award BPA covers the provision of biological materials, including custom oligonucleotides and sequencing services, to support NINDS's biomedical research mission. The BPA has an ultimate completion date of May 31,...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) with a ceiling value of $37,393,571 to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The IDC, titled the "Drug Manufacturing and Formulation Program (DMFP)," provides a broad range of pharmaceutical research and development...
This is a single-award Indefinite Delivery Contract issued by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit organization that manufactures biologics. The Diagnostics Pre-Clinical Services Program IDIQ contract has a potential value of $24,000,000 over a 7-year ordering period ending June 2030. Under this contract, ABL will provide a broad range of preclinical diagnostic...
This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke to Leidos, Inc. as a multiple award contract to provide manufacturing and nonclinical services in support of developing therapeutic biotechnology products for neurological-related disorders. Valued at up to $149.2 million, the contract has a performance period through September 2030. Under the master contract, Leidos...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian federal agency, has awarded Psychogenics Inc., a for-profit preclinical contract research organization, a $69.1 million cost-plus-fixed-fee delivery order contract to provide screening of investigational agents through the NINDS Preclinical Screening Platform for Pain (PSPP) program. This delivery order is part of a larger $49.9 million single-award indefinite delivery contract between NINDS and Psychogenics to...